comprehensive -WSS

comprehensive

author：knowledge 2025-09-29 21:02:33 - browse：84

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： For AI in health care standards, federal regulators join with industry group

explore

WSS

An inside look at PIPEs, biotech's buzzy new financing tool

Harvard's David Sinclair gets blowback over aging

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Biden's 'march

Biden's 'march

State of the Union pitch: Bigger Medicare drug price negotiations

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

In search for therapies for solid tumors, companies turn to claudin

Supreme Court strikes down use of affirmative action

Longer MASH drug regimen improved liver, Akero study finds

Heart attack and stroke risk calculators need revising

Longer MASH drug regimen improved liver, Akero study finds

Drug repurposing or repositioning? The language matters

Readout Newsletter: BridgeBio, Akero, and human embryo models

As demand for Covid shots wanes, Moderna seeks its next success

Medical device lobby: We're tired of waiting on Medicare coverage

hotspot

State of the Union pitch: Bigger Medicare drug price negotiations

In search for therapies for solid tumors, companies turn to claudin

Families look for replacement for GSK asthma drug Flovent

For AI in health care standards, federal regulators join with industry group

Families look for replacement for GSK asthma drug Flovent

FDA does about

entertainment

entertainment

explore

focus